Skip to main content
SpringerLink
Log in
Book cover

Occupational Cancers pp 409–422Cite as

Malignant Tumors of the Female Reproductive System

  • Chapter
  • First Online:

Abstract

Cancers of the female reproductive system – namely, cancer of the cervix uteri (cervical cancer); cancer of the corpus uteri (which includes mostly adenocarcinomas originating in the endometrium and some other rarer cancers, such as sarcomas); ovarian, vulvar, vaginal, and fallopian tube cancers; and choriocarcinoma – are an important cause of cancer morbidity and mortality worldwide. Cervical, endometrial, and ovarian cancers are relatively common, while the other cancers of the female reproductive system are very rare. Asbestos is considered to be carcinogenic to the human ovary, and tetrachloroethylene is considered to be probably carcinogenic to the human cervix uteri. Exposure to other agents with sufficient evidence of carcinogenicity generally occurs through medical treatments (diethylstilbestrol, oral contraceptives or hormone replacement therapy, X-radiation, and γ-radiation), environmental exposure (atomic bomb survivors), personal lifestyle habits (smoking, perineal use of talc-based body powder), or infections with other viruses (HIV1 and several HPV types).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Merritt MA, Cramer DW. Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark. 2011;9:287–305.

    Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon: International Agency for Research on Cancer; 2010. Available at http://globocan.iarc.fr. Accessed August 2011

  3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, Vol VIII. IARC scientific publication no. 155. Lyon: International Agency for Research on Cancer; 2002.

    Google Scholar 

  4. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24 Suppl 3:S3/11–25.

    Google Scholar 

  5. Bosch FX, Cardis E. Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer. 1990;46:178–84.

    Article  CAS  PubMed  Google Scholar 

  6. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207–25.

    Article  CAS  PubMed  Google Scholar 

  7. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.

    Article  PubMed  Google Scholar 

  8. Andrae B, Andersson TML, Lambert PC, Kemetli L, Silfverdal L, Strander B, et al. Screening and cervical cancer cure: a population-based cohort study. Br Med J. 2012;344:e900.

    Article  Google Scholar 

  9. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827–39.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13:295–308.

    Article  CAS  PubMed  Google Scholar 

  11. Sherman ME, Sturgeon S, Brinton L, Kurman RJ. Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis. J Cell Biochem Suppl. 1995;23:160–4.

    Article  CAS  PubMed  Google Scholar 

  12. Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer. 2000;89:1758–64.

    Article  CAS  PubMed  Google Scholar 

  13. Faquin WC, Fitzgerald JT, Lin MC, Boynton KA, Muto MG, Mutter GL. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am J Clin Pathol. 2000;113:576–82.

    Article  CAS  PubMed  Google Scholar 

  14. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93–108.

    Article  CAS  PubMed  Google Scholar 

  16. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008;630:148–65.

    Article  CAS  PubMed  Google Scholar 

  17. IARC. Monographs on the evaluation of carcinogenic risks to humans, A review of human carcinogens. Part E: personal habits and indoor combustions, vol. 100. Lyon: International Agency for Research on Cancer; 2012.

    Google Scholar 

  18. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.

    Google Scholar 

  19. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4.

    Article  PubMed  Google Scholar 

  20. McMeekin DS. Sarcoma of the uterus. In: DiSaia PA, Creasman WT, editors. Clinical gynecologic oncology. 7th ed. Philadelphia: Mosby Elsevier; 2007.

    Google Scholar 

  21. McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12:687–90.

    Article  CAS  PubMed  Google Scholar 

  22. Nordal RR, Thoresen SO. Uterine sarcomas in Norway 1956–1992: incidence, survival and mortality. Eur J Cancer. 1997;33:907–11.

    Article  CAS  PubMed  Google Scholar 

  23. Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009;54:355–64.

    Article  PubMed  Google Scholar 

  24. Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, et al. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990–2003). Int J Gynecol Cancer. 2006;16:1358–63.

    Article  CAS  PubMed  Google Scholar 

  25. Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol. 2008;111:74–81.

    Article  PubMed  Google Scholar 

  26. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93:204–8.

    Article  PubMed  Google Scholar 

  27. Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst. 1986;76:399–402.

    CAS  PubMed  Google Scholar 

  28. Schwartz SM, Weiss NS, Daling JR, Gammon MD, Liff JM, Watt J, et al. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer. 1996;77:717–24.

    Article  CAS  PubMed  Google Scholar 

  29. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol. 2002;20:2758–60.

    PubMed  Google Scholar 

  30. Arenas M, Rovirosa A, Hernandez V, Ordi J, Jorcano S, Mellado B, Biete A. Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer. 2006;16:861–5.

    Article  CAS  PubMed  Google Scholar 

  31. Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol. 2009;472:413–37.

    Article  PubMed  Google Scholar 

  32. Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer. 2003;97(10 Suppl):2631–42.

    Article  PubMed  Google Scholar 

  33. Averette HE, Nguyen H. Gynecologic cancer. In: Murphy GP, Lawrence I, Lenhard RE, editors. American Cancer Society textbook of clinical oncology. Atlanta: American Cancer Society; 1995. p. 552–79.

    Google Scholar 

  34. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiere T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.

    Article  CAS  PubMed  Google Scholar 

  35. Tavassoli FA, Devilee P. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: International Agency for Research on Cancer; 2003.

    Google Scholar 

  36. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–81.

    Article  CAS  PubMed  Google Scholar 

  37. Riska A, Leminen A. Determinants of incidence of primary fallopian tube carcinoma (PFTC). Methods Mol Biol. 2009;472:387–96.

    Article  PubMed  Google Scholar 

  38. IARC. Agents classified by the IARC Monographs, volumes 1–102. http://monographs.iarc.fr/ENG/Classification/Classifications GroupOrder.pdf. Accessed Aug 2011.

  39. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens–part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10:453–4.

    Article  PubMed  Google Scholar 

  40. IARC. Monographs on the evaluation of carcinogenic risks to humans, Dry cleaning, some chlorinated solvents and other industrial chemicals, vol. 63. Lyon: International Agency for Research on Cancer; 1995.

    Google Scholar 

  41. Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med. 1994;36:867–74.

    CAS  PubMed  Google Scholar 

  42. Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers: an update. Am J Ind Med. 2001;39:121–32.

    Article  CAS  PubMed  Google Scholar 

  43. Blair A, Stewart PA, Tolbert PE, Grauman D, Moran FX, Vaught J, Rayner J. Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med. 1990;47:162–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Blair A, Petralia SA, Stewart PA. Extended mortality follow-up of a cohort of dry cleaners. Ann Epidemiol. 2003;13:50–6.

    Article  PubMed  Google Scholar 

  45. Travier N, Gridley G, De Roos AJ, Plato N, Moradi T, Boffetta P. Cancer incidence of dry cleaning, laundry and ironing workers in Sweden. Scand J Work Environ Health. 2002;28:341–8.

    Article  PubMed  Google Scholar 

  46. Selden AI, Ahlborg Jr G. Cancer morbidity in Swedish dry-cleaners and laundry workers: historically prospective cohort study. Int Arch Occup Environ Health. 2011;84:435–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Acheson ED, Gardner MJ, Pippard EC, Grime LP. Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up. Br J Ind Med. 1982;39:344–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. McDonald JC, Harris JM, Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med. 2006;63:852–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Vasama-Neuvonen K, Pukkala E, Paakkulainen H, Mutanen P, Weiderpass E, Boffetta P, et al. Ovarian cancer and occupational exposures in Finland. Am J Ind Med. 1999;36:83–9.

    Article  CAS  PubMed  Google Scholar 

  50. IARC. Monographs on the evaluation of carcinogenic risks to humans, Ionizing radiation. Part 1: X- and gamma (γ)-radiation, and neutrons, vol. 75. Lyon: International Agency for Research on Cancer; 2000.

    Google Scholar 

  51. NTP. Report on carcinogens. 12th ed. Research Triangle Park: US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2011.

    Google Scholar 

  52. Kauppinen T, Toikkanen J, Pedersen D, Young R, Ahrens W, Boffetta P, et al. Occupational exposure to carcinogens in the European Union. Occup Environ Med. 2000;57:10–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. ATSDR. Toxicological profile for tetrachloroethylene (PERC). Atlanta: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention; 1997. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=265&tid=48. Accessed Aug 2011.

  54. Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med. 1995;37:797–806.

    Article  CAS  PubMed  Google Scholar 

  55. Savitz DA, Andrews KW, Brinton LA. Occupation and cervical cancer. J Occup Environ Med. 1995;37:357–61.

    Article  CAS  PubMed  Google Scholar 

  56. Sala M, Dosemeci M, Zahm SH. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states. J Occup Environ Med. 1998;40:632–9.

    Article  CAS  PubMed  Google Scholar 

  57. Carpenter L, Roman E. Cancer and occupation in women: identifying associations using routinely collected national data. Environ Health Perspect. 1999;107 Suppl 2:299–303.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer – follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48:646–790.

    Article  CAS  PubMed  Google Scholar 

  59. Wesseling C, Ahlbom A, Antich D, Rodriguez AC, Castro R. Cancer in banana plantation workers in Costa Rica. Int J Epidemiol. 1996;25:1125–31.

    Article  CAS  PubMed  Google Scholar 

  60. Settimi L, Comba P, Carrieri P, Boffetta P, Magnani C, Terracini B, et al. Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med. 1999;36:135–41.

    Article  CAS  PubMed  Google Scholar 

  61. Colt JS, Stallones L, Cameron LL, Dosemeci M, Zahm SH. Proportionate mortality among US migrant and seasonal farm workers in twenty-four states. Am J Ind Med. 2001;40:604–111.

    Article  CAS  PubMed  Google Scholar 

  62. Ma F, Fleming LE, Lee DJ, Trapido E, Gerace TA. Cancer incidence in Florida professional firefighters, 1981 to 1999. J Occup Environ Med. 2006;48:883–8.

    Article  PubMed  Google Scholar 

  63. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33:336–43.

    Article  PubMed  Google Scholar 

  64. Weiderpass E, Pukkala E, Vasama-Neuvonen K, Kauppinen T, Vainio H, Paakkulainen H, et al. Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med. 2001;39:572–80.

    Article  CAS  PubMed  Google Scholar 

  65. Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control. 2001;12:365–74.

    Article  CAS  PubMed  Google Scholar 

  66. Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med. 2004;46:147–53.

    Article  PubMed  Google Scholar 

  67. Betenia N, Costello S, Eisen EA. Risk of cervical cancer among female autoworkers exposed to metalworking fluids. Scand J Work Environ Health. 2012;38:78–83.

    Article  CAS  PubMed  Google Scholar 

  68. Laakkonen A, Verkasalo PK, Nevalainen A, Kauppinen T, Kyyronen P, Pukkala EI. Moulds, bacteria and cancer among Finns: an occupational cohort study. Occup Environ Med. 2008;65:489–93.

    Article  CAS  PubMed  Google Scholar 

  69. Petralia SA, Dosemeci M, Adams EE, Zahm SH. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984–1993. Am J Ind Med. 1999;36:159–65.

    Article  CAS  PubMed  Google Scholar 

  70. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, et al. High breast cancer incidence rates among California teachers: results from the California teachers study (United States). Cancer Causes Control. 2002;13:625–35.

    Article  PubMed  Google Scholar 

  71. MacArthur AC, Le ND, Abanto ZU, Gallagher RP. Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950–94. Occup Med (Lond). 2007;57:246–53.

    Article  Google Scholar 

  72. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007;67:10618–22.

    Article  CAS  PubMed  Google Scholar 

  73. John EM, Koo J, Horn-Ross PL. Lifetime physical activity and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:1276–83.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA data bases. Maturitas. 2012;72:56–60.

    Article  CAS  PubMed  Google Scholar 

  75. Concha-Barrientos M, Nelson DI, Driscoll T, Steenland NK, Punnett L, Fingerhut MA, et al. Selected occupational risk factors. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of diseases attributable to selected major risk factors, vol. 1 & 2. Geneva: World Health Organization; 2004

    Google Scholar 

  76. ATSDR. Toxicological profile for asbestos. Atlanta: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention; 2001. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=30&tid=4. Accessed Aug 2011.

  77. Heller DS, Gordon RE, Westhoff C, Gerber S. Asbestos exposure and ovarian fiber burden. Am J Ind Med. 1996;29:435–9.

    Article  CAS  PubMed  Google Scholar 

  78. Camargo MC, Stayner LT, Straif K, et al. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect. 2011;119:1211–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  79. Bulbulyan MA, Ilychova SA, Zahm SH, Astashevsky SV, Zaridze DG. Cancer mortality among women in the Russian printing industry. Am J Ind Med. 1999;36:166–71.

    Article  CAS  PubMed  Google Scholar 

  80. IARC. Monographs on the evaluation of carcinogenic risks to humans, A review of human carcinogens. Part D: radiation, vol. 100. Lyon: International Agency for Research on Cancer; 2012.

    Google Scholar 

  81. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 2008 report to the general assembly with scientific annexes, vol. 1. New York: United Nations; 2010.

    Google Scholar 

  82. Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, et al. Cancer incidence in the US radiologic technologists health study, 1983–1998. Cancer. 2003;97:3080–9.

    Article  PubMed  Google Scholar 

  83. Doody MM, Mandel JS, Lubin JH, Boice Jr JD. Mortality among United States radiologic technologists, 1926–90. Cancer Causes Control. 1998;9:67–75.

    Article  CAS  PubMed  Google Scholar 

  84. Wang JX, Zhang LA, Li BX, Zhao YC, Wang ZQ, Zhang JY, Aoyama T. Cancer incidence and risk estimation among medical x-ray workers in China, 1950–1995. Health Phys. 2002;82:455–66.

    Article  CAS  PubMed  Google Scholar 

  85. McGeoghegan D, Binks K. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946–95. J Radiol Prot. 2000;20:111–37.

    Article  CAS  PubMed  Google Scholar 

  86. Telle-Lamberton M, Bergot D, Gagneau M, Samson E, Giraud JM, Neron MO, Hubert P. Cancer mortality among French atomic energy commission workers. Am J Ind Med. 2004;45:34–44.

    Article  CAS  PubMed  Google Scholar 

  87. Ashmore JP, Krewski D, Zielinski JM, Jiang H, Semenciw R, Band PR. First analysis of mortality and occupational radiation exposure based on the national dose registry of Canada. Am J Epidemiol. 1998;148:564–74.

    Article  CAS  PubMed  Google Scholar 

  88. Sont WN, Zielinski JM, Ashmore JP, Jiang H, Krewski D, Fair ME, et al. First analysis of cancer incidence and occupational radiation exposure based on the national dose registry of Canada. Am J Epidemiol. 2001;153:309–18.

    Article  CAS  PubMed  Google Scholar 

  89. Shields T, Gridley G, Moradi T, Adami J, Plato N, Dosemeci M. Occupational exposures and the risk of ovarian cancer in Sweden. Am J Ind Med. 2002;42:200–13.

    Article  PubMed  Google Scholar 

  90. IARC. Monographs on the evaluation of carcinogenic risks to humans, A review of human carcinogens. Part A: pharmaceuticals, vol. 100. Lyon: International Agency for Research on Cancer; 2011.

    Google Scholar 

  91. Heron RJ, Pickering FC. Health effects of exposure to active pharmaceutical ingredients (APIs). Occup Med (Lond). 2003;53:357–62.

    Article  CAS  Google Scholar 

  92. Edling C, Friis L, Mikoczy Z, Hagmar L, Lindfors P. Cancer incidence among pharmaceutical workers. Scand J Work Environ Health. 1995;21:116–23.

    Article  CAS  PubMed  Google Scholar 

  93. Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20:22–6.

    Article  CAS  PubMed  Google Scholar 

  94. Hansen J, Olsen JH, Larsen AI. Cancer morbidity among employees in a Danish pharmaceutical plant. Int J Epidemiol. 1994;23:891–8.

    Article  CAS  PubMed  Google Scholar 

  95. Guo J, Kauppinen T, Kyyronen P, Heikkila P, Lindbohm ML, Pukkala E. Risk of esophageal, ovarian, testicular, kidney and bladder cancers and leukemia among finnish workers exposed to diesel or gasoline engine exhaust. Int J Cancer. 2004;111:286–92.

    Article  CAS  PubMed  Google Scholar 

  96. Robinson CF, Walker JT. Cancer mortality among women employed in fast-growing U.S. occupations. Am J Ind Med. 1999;36:186–92.

    Article  CAS  PubMed  Google Scholar 

  97. Nanni O, Ravaioli A, Bucchi L, Falcini F, Ricci R, Buiatti E, Amadori D. Relative and absolute cancer mortality of women in agriculture in northern Italy. Eur J Cancer Prev. 2005;14:337–44.

    Article  CAS  PubMed  Google Scholar 

  98. Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, et al. An update of cancer incidence in the agricultural health study. J Occup Environ Med. 2010;52:1098–105.

    Article  PubMed Central  PubMed  Google Scholar 

  99. IARC. Monographs on the evaluation of carcinogenic risks to humans, Some aromatic amines, organic dyes and related exposures, vol. 99. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  100. Takkouche B, Regueira-Mendez C, Montes-Martinez A. Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol. 2009;38:1512–31.

    Article  PubMed  Google Scholar 

  101. Quach T, Doan-Billing PA, Layefsky M, Nelson D, Nguyen KD, Okahara L, et al. Cancer incidence in female cosmetologists and manicurists in California, 1988–2005. Am J Epidemiol. 2010;172:691–9.

    Article  PubMed  Google Scholar 

  102. Czene K, Tiikkaja S, Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer. 2003;105:108–12.

    Article  CAS  PubMed  Google Scholar 

  103. Mabuchi K, Bross DS, Kessler II. Epidemiology of cancer of the vulva. A case-control study. Cancer. 1985;55:1843–8.

    Article  CAS  PubMed  Google Scholar 

  104. Riska A, Martinsen J, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, et al. Occupation and risk of primary fallopian tube carcinoma in Nordic countries. Int J Cancer. 2012;13:186–92.

    Article  Google Scholar 

  105. Loukovaara M, Pukkala E, Lehtovirta P, Leminen A. Epidemiology of choriocarcinoma in Finland, 1953 to 1999. Gynecol Oncol. 2004;92:252–5.

    Article  PubMed  Google Scholar 

  106. Reid A, Heyworth J, de Klerk N, Musk AW. Asbestos exposure and gestational trophoblastic disease: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2009;18:2895–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Registry of Norway, Oslo, Norway

    Elisabete Weiderpass MD, MSc, PhD

  2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    Elisabete Weiderpass MD, MSc, PhD

  3. Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway

    Elisabete Weiderpass MD, MSc, PhD

  4. Department of Genetic Epidemiology, Folkhälsan Research Center, Helsinki, Finland

    Elisabete Weiderpass MD, MSc, PhD

  5. Département de Santé environnementale et santé au travail, École de santé publique, Université de Montréal, Montreal, QC, Canada

    France Labrèche PhD

Authors
  1. Elisabete Weiderpass MD, MSc, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. France Labrèche PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisabete Weiderpass MD, MSc, PhD .

Editor information

Editors and Affiliations

  1. Helsinki University Central Hospital and Finnish Institute of Occupational Health, Helsinki, Finland

    Sisko Anttila

  2. Icahn School of Medicine at Mount Sinai, New York, New York, USA

    Paolo Boffetta

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Weiderpass, E., Labrèche, F. (2014). Malignant Tumors of the Female Reproductive System. In: Anttila, S., Boffetta, P. (eds) Occupational Cancers. Springer, London. https://doi.org/10.1007/978-1-4471-2825-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2825-0_23

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2824-3

  • Online ISBN: 978-1-4471-2825-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation